Clinical Trial Update: Researching an Effect of GLP-1 Agonist on Liver STeatosis (REALIST) [Phase 4]

View source ↗

Summary

A Phase 4 trial investigating the effect of a GLP-1 agonist on liver steatosis in adults with type 2 diabetes and nonalcoholic steatohepatitis (NASH).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Nonalcoholic Steatohepatitis
• Type 2 Diabetes Mellitus

Snippet

Sponsor: Central Hospital, Nancy, France | Conditions: Diabetes Mellitus, Type 2, NASH - Nonalcoholic Steatohepatitis | Phase 4 | Status: UNKNOWN